MSI Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $392K | Sell |
3,203
-1,087
| -25% | -$133K | 0.01% | 801 |
|
|
2016
Q3 | $526K | Buy |
4,290
+44
| +1% | +$5.4K | 0.02% | 655 |
|
|
2016
Q2 | $496K | Sell |
4,246
-709
| -14% | -$82.8K | 0.02% | 638 |
|
|
2016
Q1 | $690K | Buy |
4,955
+929
| +23% | +$129K | 0.03% | 487 |
|
|
2015
Q4 | $768K | Buy |
4,026
+2,767
| +220% | +$528K | 0.03% | 435 |
|
|
2015
Q3 | $197K | Buy |
1,259
+568
| +82% | +$88.9K | 0.02% | 652 |
|
|
2015
Q2 | $125K | Sell |
691
-3
| -0.4% | -$543 | 0.01% | 904 |
|
|
2015
Q1 | $120K | Buy |
694
+11
| +2% | +$1.9K | 0.01% | 941 |
|
|
2014
Q4 | $126K | Sell |
683
-97
| -12% | -$17.9K | 0.01% | 724 |
|
|
2014
Q3 | $129K | Buy |
780
+11
| +1% | +$1.82K | 0.02% | 730 |
|
|
2014
Q2 | $120K | Sell |
769
-159
| -17% | -$24.8K | 0.02% | 742 |
|
|
2014
Q1 | $141K | Sell |
928
-757
| -45% | -$115K | 0.02% | 647 |
|
|
2013
Q4 | $224K | Buy |
1,685
+210
| +14% | +$27.9K | 0.03% | 457 |
|
|
2013
Q3 | $171K | Sell |
1,475
-333
| -18% | -$38.6K | 0.03% | 494 |
|
|
2013
Q2 | $167K | Buy |
+1,808
| New | +$167K | 0.03% | 468 |
|